Suppr超能文献

视网膜动脉/静脉阻塞与血管性痴呆风险的关联。

Associations Between Retinal Artery/Vein Occlusions and Risk of Vascular Dementia.

机构信息

Department of Ophthalmology, University of Washington, Seattle, WA, USA.

Department of Medicine, University of Washington, Seattle, WA, USA.

出版信息

J Alzheimers Dis. 2021;81(1):245-253. doi: 10.3233/JAD-201492.

Abstract

BACKGROUND

Vascular disease is a risk factor for Alzheimer's disease (AD) and related dementia in older adults. Retinal artery/vein occlusion (RAVO) is an ophthalmic complication of systemic vascular pathology. Whether there are associations between RAVO and dementia risk is unknown.

OBJECTIVE

To determine whether RAVOs are associated with an increased risk of developing vascular dementia or AD.

METHODS

Data from Adult Changes in Thought (ACT) study participants were analyzed. This prospective, population-based cohort study followed older adults (age ≥65 years) who were dementia-free at enrollment for development of vascular dementia or AD based on research criteria. RAVO diagnoses were extracted from electronic medical records. Cox-regression survival analyses were stratified by APOEɛ4 genotype and adjusted for demographic and clinical factors.

RESULTS

On review of 41,216 person-years (4,743 participants), 266 (5.6%) experienced RAVO. APOEɛ4 carriers who developed RAVO had greater than four-fold higher risk for developing vascular dementia (Hazard Ratio [HR] 4.54, 95% Confidence Interval [CI] 1.86, 11.10, p = 0.001). When including other cerebrovascular disease (history of carotid endarterectomy or transient ischemic attack) in the model, the risk was three-fold higher (HR 3.06, 95% CI 1.23, 7.62). No other conditions evaluated in the secondary analyses were found to confound this relationship. There was no effect in non-APOEɛ4 carriers (HR 1.03, 95% CI 0.37, 2.80). There were no significant associations between RAVO and AD in either APOE group.

CONCLUSION

Older dementia-free patients who present with RAVO and carry the APOEɛ4 allele appear to be at higher risk for vascular dementia.

摘要

背景

血管疾病是老年人阿尔茨海默病(AD)和相关痴呆的危险因素。视网膜动脉/静脉阻塞(RAVO)是全身血管病理学的眼部并发症。RAVO 是否与痴呆风险相关尚不清楚。

目的

确定 RAVO 是否与血管性痴呆或 AD 的发病风险增加相关。

方法

分析来自成人思维变化(ACT)研究参与者的数据。这项前瞻性、基于人群的队列研究随访了在入组时无痴呆的老年人(年龄≥65 岁),根据研究标准确定血管性痴呆或 AD 的发病情况。从电子病历中提取 RAVO 诊断。Cox 回归生存分析按 APOEɛ4 基因型分层,并根据人口统计学和临床因素进行调整。

结果

在审查了 41216 人年(4743 名参与者)后,266 人(5.6%)发生了 RAVO。发生 RAVO 的 APOEɛ4 携带者发生血管性痴呆的风险增加了四倍以上(风险比[HR]4.54,95%置信区间[CI]1.86,11.10,p=0.001)。当在模型中包括其他脑血管疾病(颈动脉内膜切除术或短暂性脑缺血发作史)时,风险增加了三倍(HR 3.06,95%CI 1.23,7.62)。在二次分析中评估的其他条件均未发现混淆这种关系。在非 APOEɛ4 携带者中无此效应(HR 1.03,95%CI 0.37,2.80)。在 APOE 组中,RAVO 与 AD 均无显著相关性。

结论

无痴呆的老年患者出现 RAVO 并携带 APOEɛ4 等位基因似乎发生血管性痴呆的风险更高。

相似文献

引用本文的文献

1
Retinal vasculometry associations with cognition status in UK Biobank.英国生物银行中视网膜血管测量与认知状态的关联。
Alzheimers Dement (Amst). 2025 Feb 24;17(1):e270087. doi: 10.1002/dad2.70087. eCollection 2025 Jan-Mar.
2
Associations between dementia and exposure to topical glaucoma medications.痴呆症与局部青光眼药物暴露之间的关联。
J Alzheimers Dis. 2025 Feb;103(3):679-686. doi: 10.1177/13872877241305745. Epub 2025 Jan 21.
3
Associations Between Retinal Vascular Occlusions and Dementia.视网膜血管阻塞与痴呆症之间的关联。
Healthcare (Basel). 2024 Nov 26;12(23):2371. doi: 10.3390/healthcare12232371.
5
[Internistic clarification of retinal vascular occlusions].[视网膜血管阻塞的内科诊疗阐释]
Ophthalmologie. 2023 Dec;120(12):1287-1294. doi: 10.1007/s00347-023-01961-y. Epub 2023 Nov 27.

本文引用的文献

5
Stroke and dementia risk: A systematic review and meta-analysis.中风和痴呆风险:系统评价和荟萃分析。
Alzheimers Dement. 2018 Nov;14(11):1416-1426. doi: 10.1016/j.jalz.2018.06.3061. Epub 2018 Aug 31.
7
APOE Alleles and Extreme Human Longevity.载脂蛋白 E 等位基因与人类极端长寿。
J Gerontol A Biol Sci Med Sci. 2019 Jan 1;74(1):44-51. doi: 10.1093/gerona/gly174.
8
Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.心肌梗死幸存者发生血管性痴呆的风险更高。
Circulation. 2018 Feb 6;137(6):567-577. doi: 10.1161/CIRCULATIONAHA.117.029127. Epub 2017 Oct 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验